Cefaclor (C7)

1223
1208.00 ₴
Available

Cefaclor is a second-generation cephalosporin antibiotic for oral use. It was first synthesized by the American company Eli Lilly and is known under the trade name "Ceclor".

Allergy to antibiotics can occur suddenly, even on the first dose. The immune system may be sensitive to cefaclor, posing a risk of allergic reactions. Cross-hypersensitivity is common in patients allergic to penicillins due to structural similarity. The rate of cross-reactivity among patients with a positive penicillin skin test is 6-10%. Timely detection of sensitization to cefaclor helps prevent dangerous reactions and manage the patient’s immune status.

  • Diagnosis of allergic reactions to cefaclor.
  • Assessment of sensitization level and risk of allergy development.
  • Monitoring the effectiveness of ongoing therapy.
  • Evaluation of sensitization level after allergen exposure has been eliminated.
  • Assessment of immune system status.

FEIA (Fluorescence Enzyme Immunoassay) – quantitative determination.

Please note that the research method and reference values may vary depending on the equipment and test systems used.

  • Blood should be drawn in the morning on an empty stomach or 4 hours after eating.
  • Drinking plain still water is allowed.
  • Do not smoke for 30 minutes before the test.
  • For children under 1 year – do not feed 30-40 minutes before the test; for children 1-5 years – 2-3 hours fasting.

Viewed tests